How severe is CVE-2023-30989?

CVE-2023-30989 has a CVSS 3.x base score of 8.4, rated high severity. It is exploitable over local access with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.

Is CVE-2023-30989 being actively exploited?

It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (7th percentile), an estimate of the probability of exploitation in the next 30 days.

What products are affected by CVE-2023-30989?

CVE-2023-30989 primarily affects Ibm I. In total, 4 product configurations (CPEs) are listed as vulnerable; see the affected-products list for the exact versions.

How do I fix CVE-2023-30989?

Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.

When was CVE-2023-30989 published?

CVE-2023-30989 was published on 2023-07-16 and last updated on 2026-06-17.

CVE-2023-30989

CVE-2023-30989 is a high-severity vulnerability in Ibm I with a CVSS 3.x base score of 8.4. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-269.

Key facts

Severity: High (CVSS 3.x base score 8.4)
EPSS exploit prediction: 0% (7th percentile)
Actively exploited: Not listed in CISA KEV
Weakness: CWE-269
Affected product: Ibm I
Published: 2023-07-16
Last modified: 2026-06-17

Description

IBM Performance Tools for i 7.2, 7.3, 7.4, and 7.5 contains a local privilege escalation vulnerability. A malicious actor with command line access to the host operating system can elevate privileges to gain all object access to the host operating system. IBM X-Force ID: 254017.

Frequently asked questions

What is CVE-2023-30989?: IBM Performance Tools for i 7.2, 7.3, 7.4, and 7.5 contains a local privilege escalation vulnerability. A malicious actor with command line access to the host operating system can elevate privileges to gain all object access to the host operating system. IBM X-Force ID: 254017.
How severe is CVE-2023-30989?: CVE-2023-30989 has a CVSS 3.x base score of 8.4, rated high severity. It is exploitable over local access with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.
Is CVE-2023-30989 being actively exploited?: It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (7th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2023-30989?: CVE-2023-30989 primarily affects Ibm I. In total, 4 product configurations (CPEs) are listed as vulnerable; see the affected-products list for the exact versions.
How do I fix CVE-2023-30989?: Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
When was CVE-2023-30989 published?: CVE-2023-30989 was published on 2023-07-16 and last updated on 2026-06-17.

References

Affected products (4)

cpe:2.3:a:ibm:i:7.2:*:*:*:*:*:*:*
cpe:2.3:a:ibm:i:7.3:*:*:*:*:*:*:*
cpe:2.3:a:ibm:i:7.4:*:*:*:*:*:*:*
cpe:2.3:a:ibm:i:7.5:*:*:*:*:*:*:*

More vulnerabilities in Ibm I

CVE-2026-16860 — Critical (CVSS 9.9): IBM i 7.6, 7.5, 7.4, and 7.3 could allow a remote authenticated attacker to execute arbitrary code due to an…
CVE-2026-17083 — Critical (CVSS 9.8): IBM i 7.6, 7.5, 7.4, and 7.3 could allow a remote attacker to execute arbitrary code due to a stack-based buffer…
CVE-2026-17218 — Critical (CVSS 9.8): IBM i 7.6, 7.5, 7.4, and 7.3 could allow a remote attacker to execute arbitrary code due to an out-of-bounds write.
CVE-2026-17276 — Critical (CVSS 9.6): IBM i 7.6, 7.5, 7.4, and 7.3 could allow a remote authenticated attacker to escalate privileges due to improper…
CVE-2026-18193 — High (CVSS 8.9): IBM i 7.6, 7.5, 7.4, and 7.3 could allow a remote attacker to bypass security restrictions due to improper validation…
CVE-2026-18099 — High (CVSS 8.9): IBM i 7.6, 7.5, 7.4, and 7.3 could allow a remote authenticated attacker to execute arbitrary script code due to…

All CVEs affecting Ibm I →

Other CWE-269 (Improper Privilege Management) vulnerabilities

CVE-2026-60366 — Critical (CVSS 10.0): Vulnerability in the Oracle Platform Security for Java product of Oracle Fusion Middleware (component: Centralized…
CVE-2026-31852 — Critical (CVSS 10.0): Jellyfin is an open-source media system. The code-quality.yml GitHub Actions workflow in jellyfin/jellyfin-ios is…
CVE-2025-20282 — Critical (CVSS 10.0): A vulnerability in an internal API of Cisco ISE and Cisco ISE-PIC could allow an unauthenticated, remote attacker to…
CVE-2025-0505 — Critical (CVSS 10.0): On Arista CloudVision systems (virtual or physical on-premise deployments), Zero Touch Provisioning can be used to gain…
CVE-2023-48418 — Critical (CVSS 10.0): In checkDebuggingDisallowed of DeviceVersionFragment.java, there is a possible way to access adb before SUW…
CVE-2023-48419 — Critical (CVSS 10.0): An attacker in the wifi vicinity of a target Google Home can spy on the victim, resulting in Elevation of Privilege

Browse all CWE-269 (Improper Privilege Management) vulnerabilities →